Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BROWN J. B., KELLAR R., MATTHEW G. D. Preliminary observations on urinary oestrogen excretion in certain gynaecological disorders. J Obstet Gynaecol Br Emp. 1959 Apr;66(2):177–211. doi: 10.1111/j.1471-0528.1959.tb01999.x. [DOI] [PubMed] [Google Scholar]
- Bayard F., Damilano S., Robel P., Baulieu E. E. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. J Clin Endocrinol Metab. 1978 Apr;46(4):635–648. doi: 10.1210/jcem-46-4-635. [DOI] [PubMed] [Google Scholar]
- Bye P. G. Review of the status of oestrogen replacement therapy. Postgrad Med J. 1978;54 (Suppl 2):7–10. [PubMed] [Google Scholar]
- CAMPBELL P. E., BARTER R. A. The significance of a typical endometrial hyperplasia. J Obstet Gynaecol Br Commonw. 1961 Aug;68:668–672. doi: 10.1111/j.1471-0528.1961.tb02789.x. [DOI] [PubMed] [Google Scholar]
- Cooke I. D. Letter: Oestrogens as a cause of endometrial carcinoma. Br Med J. 1976 May 15;1(6019):1209–1210. doi: 10.1136/bmj.1.6019.1209-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GUSBERG S. B., KAPLAN A. L. PRECURSORS OF CORPUS CANCER. IV. ADENOMATOUS HYPERPLASIA AS STAGE O CARCINOMA OF THE ENDOMETRIUM. Am J Obstet Gynecol. 1963 Nov 1;87:662–678. [PubMed] [Google Scholar]
- Holt E. M. Out-patient diagnostic curettage. J Obstet Gynaecol Br Commonw. 1970 Nov;77(11):1043–1046. doi: 10.1111/j.1471-0528.1970.tb03457.x. [DOI] [PubMed] [Google Scholar]
- King R. J., Whitehead M. I., Campbell S., Minardi J. Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy. Postgrad Med J. 1978;54 (Suppl 2):65–68. [PubMed] [Google Scholar]
- Kontula K. Progesterone-binding protein in human myometrium. Binding site concentration in relation to endogenous progesterone and estradiol-17beta levels. J Steroid Biochem. 1975 Nov-Dec;6(11-12):1555–1561. doi: 10.1016/0022-4731(75)90214-9. [DOI] [PubMed] [Google Scholar]
- Letter: Oestrogens as a cause of endometrial carcinoma. Br Med J. 1976 May 8;1(6018):1144–1145. doi: 10.1136/bmj.1.6018.1144-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976 Jun 3;294(23):1262–1267. doi: 10.1056/NEJM197606032942304. [DOI] [PubMed] [Google Scholar]
- McBRIDE J. M. Pre-menopausal cystic hyperplasia and endometrial carcinoma. J Obstet Gynaecol Br Emp. 1959 Apr;66(2):288–296. doi: 10.1111/j.1471-0528.1959.tb02009.x. [DOI] [PubMed] [Google Scholar]
- Pollow K., Boquoi E., Lübbert H., Pollow B. Effect of gestagen therapy upon 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma. J Endocrinol. 1975 Oct;67(1):131–132. doi: 10.1677/joe.0.0670131. [DOI] [PubMed] [Google Scholar]
- Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975 Dec 4;293(23):1164–1167. doi: 10.1056/NEJM197512042932302. [DOI] [PubMed] [Google Scholar]
- Tseng L., Gurpide E. Estradiol and 20alpha-dihydroprogesterone dehydrogenase activities in human endometrium during the menstrual cycle. Endocrinology. 1974 Feb;94(2):419–423. doi: 10.1210/endo-94-2-419. [DOI] [PubMed] [Google Scholar]
- Whitehead M. I., McQueen J., Minardi J., Campbell S. Clinical considerations in the management of the menopause: the endometrium. Postgrad Med J. 1978;54 (Suppl 2):69–73. [PubMed] [Google Scholar]
- Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]